Constitutive hypercoagulability in pediatric sickle cell disease patients with hemoglobin SS genotype

CONCLUSION: Our results indicate that pediatric SCD patients with the HbSS genotype have constitutively activated hemostasis relative to HbSC patients and healthy children. It remains to be determined how treatments that improve clinical outcomes in SCD patients affect this constitutively hypercoagulable state.PMID:38605827 | PMC:PMC11004888 | DOI:10.1016/j.rpth.2024.102374
Source: Cell Research - Category: Cytology Authors: Source Type: research